ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Orlando, FL, USA:

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate...

Enrolling
Metastatic Pancreatic Cancer
Pancreatic Adenocarcinoma
Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
Alpha Tau Medical

Orlando, Florida, United States and 7 other locations

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
Viewray

Orlando, Florida, United States and 12 other locations

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Lake Mary, Florida, United States and 27 other locations

A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated d...

Enrolling
Solid Tumor
Cancer of Colon
Drug: HBI-2376

Phase 1

HUYABIO

Orlando, Florida, United States and 11 other locations

activity of MOMA-313 administered orally as a single agent or combination therapy in patients with homologous recombinant deficient solid tumors...

Enrolling
Breast Cancer
Advanced Solid Tumor
Drug: MOMA-313
Drug: Olaparib

Phase 1

MOMA Therapeutics

Lake Mary, Florida, United States and 14 other locations

as PK and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in subjects with advanced solid tumors...

Enrolling
Advanced Solid Tumor
Drug: Olaparib
Drug: XL309 (ISM3091)

Phase 1

Exelixis
Exelixis

Orlando, Florida, United States and 15 other locations

This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with adv...

Enrolling
Solid Tumor
Malignant Peripheral Nerve Sheath Tumors
Drug: MRTX1719

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Orlando, Florida, United States and 23 other locations

This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with adv...

Enrolling
Solid Tumor
Malignant Peripheral Nerve Sheath Tumors
Drug: MRTX1719

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Orlando, Florida, United States and 23 other locations

anti-CTLA4 IgG1 monoclonal antibody, as single agent and in combination with pembrolizumab in participants with advanced or metastatic solid tumors...

Active, not recruiting
Salivary Gland Cancer
Metastatic Prostate Cancer
Drug: ONC-392
Drug: Docetaxel

Phase 1, Phase 2

OncoC4

Orlando, Florida, United States and 36 other locations

The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors...

Enrolling
Breast Cancer
Salivary Gland Cancer
Drug: Zanidatamab

Phase 2

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Orlando, Florida, United States and 20 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems